|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/48 | |||
| A61K 47/10 | |||
| A61K 47/36 | |||
| A61K 38/16 |
| (11) | Number of the document | 3137053 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15721519.5 |
| Date of filing the European patent application | 2015-04-30 | |
| (97) | Date of publication of the European application | 2017-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/028647 |
| Date | 2015-04-30 |
| (87) | Number | WO 2015/168471 |
| Date | 2015-11-05 |
| (30) | Number | Date | Country code |
| 201461986346 P | 2014-04-30 | US | |
| 201462031302 P | 2014-07-31 | US |
| (72) |
FORSSEN, Eric A., US
HUGHES, Patrick M., US
RUPP, David C., US
HUNT, Terrence, US
SHIMIZU, Gary, US
FRANCIS, Joseph, US
BROIDE, Ron S., US
FERNANDEZ-SALAS, Ester, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION |
| FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION |